Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DSM-Firmenich AGDSMFF 59 Earnings Yield (Joel Greenblatt) % is 0.00% as of Jun. 2026. GuruFocus rates DSMFF with a GF Score™ of 59/100 and a GF Value™ of $82.17 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 1,626 Chemicals companies, DSM-Firmenich AG ranks worse than 59.53% on this metric.
DSM-Firmenich AG's Enterprise Value for the quarter that ended in Jun. 2026 was $27,103 Mil.
DSM-Firmenich AG's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $829 Mil. DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 0.00%.
The historical rank and industry rank for DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
DSMFF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -2.09 Med: 2.4 Max: 7.43
Current: 2.6
During the past 4 years, the highest Earnings Yield (Joel Greenblatt) of DSM-Firmenich AG was 7.43%. The lowest was -2.09%. And the median was 2.40%.
DSMFF's Earnings Yield (Joel Greenblatt) % is ranked worse than 59.53% of 1626
companies
in the Chemicals industry
Industry Median: 3.78
vs DSMFF: 2.60
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. DSM-Firmenich AG's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
DSM-Firmenich AG (OTCPK:DSMFF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
DSM-Firmenich AG Earnings Yield (Joel Greenblatt) % Related Terms
DSM-Firmenich AG Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG Earnings Yield (Joel Greenblatt) % Chart
For the Specialty Chemicals subindustry, DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG Earnings Yield (Joel Greenblatt) % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) % falls into.
DSM-Firmenich AG Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
DSM-Firmenich AGs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 0.00% mean?
DSM-Firmenich AG (DSMFF) has a Earnings Yield (Joel Greenblatt) % of 0.00% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on DSM-Firmenich AG and its competitors. According to the industry distribution chart, DSM-Firmenich AG ranks #968 out of 1626 companies in the Chemicals industry, placing it in the top 59.5%.
Is DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) % too high?
DSM-Firmenich AG's current Earnings Yield (Joel Greenblatt) % is 0.00%. Based on the distribution chart, DSM-Firmenich AG ranks #968 out of 1626 companies in the Chemicals industry, which is below the industry midpoint. Overall, DSM-Firmenich AG has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) % compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #968 out of 1626 companies for Earnings Yield (Joel Greenblatt) %. This places DSM-Firmenich AG in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.78. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Chemicals company?
The median Earnings Yield (Joel Greenblatt) % among Chemicals companies is 3.78, based on 1,626 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on DSM-Firmenich AG and its competitors. For the Chemicals industry, the median Earnings Yield (Joel Greenblatt) % is 3.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current Earnings Yield (Joel Greenblatt) % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (DSMFF) is currently considered Modestly Overvalued. The stock's GF Value™ is $82.17, compared to a current price of $91.31 — trading 11.1% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 0.00%. DSM-Firmenich AG's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For DSM-Firmenich AG (DSMFF), the current Earnings Yield (Joel Greenblatt) % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (DSMFF) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of $91.31 is trading 11.1% above its estimated GF Value™ of $82.17.
GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.
Key valuation signals for DSMFF:
Earnings Yield (Joel Greenblatt) %: 0.00%
GF Value™: $82.17 vs. price of $91.31 (11.1% above fair value)
No single metric tells the full story. See the DSMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
59GF Score
Get the complete analysis for DSMFF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSMFF has been successfully added to your 
